Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Urology Focus|May 23, 2026
The Prostate Resection Versus Minimally Invasive Surgery Evaluation Trial (PREMISE Trial) and Why We Need ItToby Page, Marcus Drake, Naomi McGregor
Trials|December 29, 2017
Challenges in implementing model-based phase I designs in a grant-funded clinical trials unitEleni Frangou, Jane Holmes, Sharon Love, et al.
BMJ Open|January 16, 2021
Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocolAnita Mansouri, Naomi McGregor, Rachel Dunn, et al.
BMJ Open|June 12, 2024
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' diseaseFaye Wolstenhulme, Irena Bibby, Michael Cole, et al.
British Journal of Cancer|January 20, 2024
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancerShibani Nicum, Naomi McGregor, Rachel Austin, et al.
Health Technology Assessment (Winchester, England)|November 11, 2025
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: CONFORM-OH pilot RCT and economic evaluationHelen Mossop, Sarah Al Ashmori, Tumi Sotire, et al.
Pilot and Feasibility Studies|September 27, 2025
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trialHelen Mossop, Sarah Al-Ashmori, Tumi Sotire, et al.
BMJ Open|October 16, 2024
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trialsJessica Griffiths, Fiona Adshead, Rustam Al-Shahi Salman, et al.
Ebiomedicine|January 1, 2025
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota researchNicola J Wyatt, Hannah Watson, Gregory R Young, et al.
BMJ Open|April 17, 2024
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicineNicola J Wyatt, Hannah Watson, Carl A Anderson, et al.
Pageof 1